These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 29704907)

  • 21. The Pain Disability Index: Effects of performance and symptom validity in mild traumatic brain injury litigants with persistent Post-Concussion pain complaints.
    Henry GK
    Clin Neuropsychol; 2023 Feb; 37(2):448-458. PubMed ID: 35109767
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Dot Counting Test adds up: Validation and response pattern analysis in a mixed clinical veteran sample.
    Soble JR; Santos OA; Bain KM; Kirton JW; Bailey KC; Critchfield EA; O'Rourke JJF; Highsmith JM; González DA
    J Clin Exp Neuropsychol; 2018 May; 40(4):317-325. PubMed ID: 28656790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Utility of various WAIS-IV Digit Span indices for identifying noncredible performance validity among cognitively impaired and unimpaired examinees.
    Webber TA; Soble JR
    Clin Neuropsychol; 2018 May; 32(4):657-670. PubMed ID: 29256334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Performance validity test failure predicts suppression of neuropsychological test results in developmentally disabled children.
    Green P; Flaro L
    Appl Neuropsychol Child; 2021 Jan; 10(1):65-81. PubMed ID: 31084379
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cognitive impairment does not cause invalid performance: analyzing performance patterns among cognitively unimpaired, impaired, and noncredible participants across six performance validity tests.
    Critchfield E; Soble JR; Marceaux JC; Bain KM; Chase Bailey K; Webber TA; Alex Alverson W; Messerly J; Andrés González D; O'Rourke JJF
    Clin Neuropsychol; 2019 Aug; 33(6):1083-1101. PubMed ID: 30475095
    [No Abstract]   [Full Text] [Related]  

  • 26. The implications of symptom validity test failure for ability-based test performance in a pediatric sample.
    Kirkwood MW; Yeates KO; Randolph C; Kirk JW
    Psychol Assess; 2012 Mar; 24(1):36-45. PubMed ID: 21767023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. False-positive rates associated with the use of multiple performance and symptom validity tests.
    Larrabee GJ
    Arch Clin Neuropsychol; 2014 Jun; 29(4):364-73. PubMed ID: 24769887
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Probable malingering and performance on the Continuous Visual Memory Test.
    Henry GK; Enders C
    Appl Neuropsychol; 2007; 14(4):267-74. PubMed ID: 18067423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A survey of neuropsychologists' use of validity tests with children and adolescents.
    Brooks BL; Ploetz DM; Kirkwood MW
    Child Neuropsychol; 2016; 22(8):1001-20. PubMed ID: 26295363
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reexamining performance validity cutoffs within the Complex Ideational Material and the Boston Naming Test-Short Form using an experimental malingering paradigm.
    An KY; Charles J; Ali S; Enache A; Dhuga J; Erdodi LA
    J Clin Exp Neuropsychol; 2019 Feb; 41(1):15-25. PubMed ID: 29943654
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Embedded Measures of Performance Validity in the Rey Complex Figure Test in a Clinical Sample of Veterans.
    Sugarman MA; Holcomb EM; Axelrod BN; Meyers JE; Liethen PC
    Appl Neuropsychol Adult; 2016; 23(2):105-14. PubMed ID: 26384155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluating the Medical Symptom Validity Test (MSVT) in a Sample of Veterans Between the Ages of 18 to 64.
    Reslan S; Axelrod BN
    Appl Neuropsychol Adult; 2017; 24(2):132-139. PubMed ID: 27045467
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pediatric validity assessment.
    Kirkwood MW
    NeuroRehabilitation; 2015; 36(4):439-50. PubMed ID: 26409492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the MMPI-2-RF for Detecting Over-reported Symptoms in a Civil Forensic and Disability Setting.
    Nguyen CT; Green D; Barr WB
    Clin Neuropsychol; 2015; 29(2):255-71. PubMed ID: 25905684
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Using the Memory Validity Profile (MVP) to detect invalid performance in youth with mild traumatic brain injury.
    Brooks BL; Sherman EMS
    Appl Neuropsychol Child; 2019; 8(4):319-325. PubMed ID: 29963927
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Red flags in the clinical interview may forecast invalid neuropsychological testing.
    Keesler ME; McClung K; Meredith-Duliba T; Williams K; Swirsky-Sacchetti T
    Clin Neuropsychol; 2017 Apr; 31(3):619-631. PubMed ID: 27846775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Symptom validity testing and its underlying psychophysiological response pattern: a preliminary study.
    Vilar-López R; Pérez-García M; Sánchez-Barrera MB; Rodríguez-Fernández A; Gómez-Río M
    Arch Clin Neuropsychol; 2011 Mar; 26(2):133-43. PubMed ID: 21169274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Establishing supplementary response time validity indicators in the Word Memory Test (WMT) and directions for future research.
    Elbaum T; Golan L; Lupu T; Wagner M; Braw Y
    Appl Neuropsychol Adult; 2020; 27(5):403-413. PubMed ID: 30724595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Embedded symptom validity tests and overall neuropsychological test performance.
    Meyers JE; Volbrecht M; Axelrod BN; Reinsch-Boothby L
    Arch Clin Neuropsychol; 2011 Feb; 26(1):8-15. PubMed ID: 21242283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Associations between Symptom Validity Test failure and scores on the MMPI-2-RF validity and substantive scales.
    Gervais RO; Wygant DB; Sellbom M; Ben-Porath YS
    J Pers Assess; 2011; 93(5):508-17. PubMed ID: 21859291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.